LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.017783
 82.01 27.76 1524 7000 0.2177 0.6521
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 82.01 27.76 194 7000 0.0277 0.2760
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 82.01 27.76 1936 7000 0.2766 0.7024
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 83.72 27.76 1552 7055 0.2200 0.6547
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 83.72 27.76 1562 7055 0.2214 0.6560
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 83.72 27.76 197 7055 0.0279 0.2780
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 83.72 27.76 1917 7055 0.2717 0.6990
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 85.42 27.76 1538 7025 0.2189 0.6535
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 85.42 27.76 1548 7025 0.2203 0.6548
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 85.42 27.76 199 7025 0.0283 0.2798
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 85.42 27.76 1959 7025 0.2788 0.7043
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 87.13 27.76 1611 6987 0.2305 0.6639
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 87.13 27.76 1624 6987 0.2324 0.6656
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 87.13 27.76 205 6987 0.0293 0.2849
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 87.13 27.76 1954 6987 0.2796 0.7047
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 88.84 27.76 1649 6965 0.2368 0.6693
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 88.84 27.76 1658 6965 0.2381 0.6704
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 88.84 27.76 193 6965 0.0277 0.2754
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 88.84 27.76 2075 6965 0.2979 0.7181
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 90.55 27.76 1635 6928 0.2360 0.6683
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 90.55 27.76 1643 6928 0.2371 0.6693
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 90.55 27.76 201 6928 0.0290 0.2822
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 90.55 27.76 1995 6928 0.2879 0.7105
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 92.25 27.76 1730 6873 0.2517 0.6815
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 92.25 27.76 1742 6873 0.2535 0.6829
MN20160318_Q01
D08